These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18940179)

  • 21. The energetics of HMG box interactions with DNA: thermodynamics of the DNA binding of the HMG box from mouse sox-5.
    Privalov PL; Jelesarov I; Read CM; Dragan AI; Crane-Robinson C
    J Mol Biol; 1999 Dec; 294(4):997-1013. PubMed ID: 10588902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.
    Chinenov Y; Kerppola TK
    Oncogene; 2001 Apr; 20(19):2438-52. PubMed ID: 11402339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermodynamics of the DNA binding reaction of transcription factor MASH-1.
    K-unne AG; Sieber M; Meierhans D; Allemann RK
    Biochemistry; 1998 Mar; 37(12):4217-23. PubMed ID: 9521744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermodynamics of the interactions of lac repressor with variants of the symmetric lac operator: effects of converting a consensus site to a non-specific site.
    Frank DE; Saecker RM; Bond JP; Capp MW; Tsodikov OV; Melcher SE; Levandoski MM; Record MT
    J Mol Biol; 1997 Apr; 267(5):1186-206. PubMed ID: 9150406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex.
    Neuberg M; Schuermann M; Hunter JB; Müller R
    Nature; 1989 Apr; 338(6216):589-90. PubMed ID: 2494459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermodynamics of specific and non-specific DNA binding by the c-Myb DNA-binding domain.
    Oda M; Furukawa K; Ogata K; Sarai A; Nakamura H
    J Mol Biol; 1998 Feb; 276(3):571-90. PubMed ID: 9551098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
    Manna PR; Eubank DW; Stocco DM
    Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA.
    Chen L; Glover JN; Hogan PG; Rao A; Harrison SC
    Nature; 1998 Mar; 392(6671):42-8. PubMed ID: 9510247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free energy calculations of the interactions of c-Jun-based synthetic peptides with the c-Fos protein.
    Zuo Z; Gandhi NS; Arndt KM; Mancera RL
    Biopolymers; 2012 Nov; 97(11):899-909. PubMed ID: 22899365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nuclear receptors NUR77 and SF1 play additive roles with c-JUN through distinct elements on the mouse Star promoter.
    Martin LJ; Tremblay JJ
    J Mol Endocrinol; 2009 Feb; 42(2):119-29. PubMed ID: 18987158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of helix-inducing constraints and downsizing upon a transcription block survival-derived functional cJun antagonist.
    Brennan A; Leech JT; Kad NM; Mason JM
    Cell Rep Phys Sci; 2022 Oct; 3(10):101077. PubMed ID: 36274790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Approach to Derive Functional Peptide Inhibitors of Transcription Factor Activity.
    Brennan A; Leech JT; Kad NM; Mason JM
    JACS Au; 2022 Apr; 2(4):996-1006. PubMed ID: 35557753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the Binding of Intrinsically Disordered Proteins from Molecular Dynamics Simulation.
    Baker CM; Best RB
    Wiley Interdiscip Rev Comput Mol Sci; 2014; 4(3):182-198. PubMed ID: 34354764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanism of methyl-dependent and spatial-specific DNA recognition of c-Jun homodimer.
    Bie LH; Fei JW; Gao J
    J Mol Model; 2021 Jul; 27(8):227. PubMed ID: 34264385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective antagonism of cJun for cancer therapy.
    Brennan A; Leech JT; Kad NM; Mason JM
    J Exp Clin Cancer Res; 2020 Sep; 39(1):184. PubMed ID: 32917236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and Characterization of a DNA-GCN4 Oligonucleotide-Peptide Conjugate: The Impact DNA/Protein Interactions on the Sensitization of DNA.
    Wityk P; Piątek R; Nowak R; Kostrzewa-Nowak D
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32784992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of promoter DNA sequence variations on the binding of EGR1 transcription factor.
    Mikles DC; Schuchardt BJ; Bhat V; McDonald CB; Farooq A
    Arch Biochem Biophys; 2014 May; 549():1-11. PubMed ID: 24657079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.